SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit Inc. is experiencing heavy selling pressure despite reporting strong quarterly growth, as investors express concerns over potential volatility in future user growth and the impact of AI-driven search trends. The community is actively debating the stock's valuation, with many users characterizing the sharp intraday decline as an overreaction and a buying opportunity, while critics highlight the platform's moderation policies and reliance on third-party search traffic.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple shares are seeing significant downward pressure after the company provided weaker-than-expected forward guidance and highlighted mounting supply chain and component cost headwinds. While the community remains divided between those viewing the decline as a major structural concern and those treating it as a long-term dip-buying opportunity, traders are closely watching the $300 support level for signs of a potential stabilization.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox shares are under significant downward pressure following an earnings report that missed bookings expectations and prompted the company to withdraw its full-year guidance. Community sentiment is deeply polarized, with many investors debating whether the massive sell-off creates a contrarian buying opportunity for long-term growth or signals a terminal decline for the platform.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is currently the focus of intense debate as investors weigh the stock's long-term potential against underwhelming financial results and persistent regulatory uncertainty. While some traders are aggressively buying the dip in anticipation of a legislative breakthrough, others are bearish due to concerns over waning retail volume and the stock's tight correlation with crypto market volatility.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is surging as the company delivers a massive AWS revenue acceleration and confirms that surging AI demand is fueling a record-breaking infrastructure backlog. The community is actively discussing whether Amazon's massive capital expenditure is finally proving that AI infrastructure can generate substantial, self-sustaining financial returns.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as retail investors react to recent trial data and ongoing legal posturing with competitors, while simultaneously tracking robust prescription numbers for oral Wegovy. The community is actively debating the stock's long-term growth potential and pipeline strength, with many participants viewing recent volatility as a strategic accumulation opportunity ahead of upcoming earnings.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is experiencing heightened community debate and volatility, driven by a disconnect between recent executive share accumulation and the lack of official corporate catalysts. Investors are actively discussing the stock's struggle to maintain upward momentum, debating whether the current price action reflects institutional accumulation, ongoing short interest, or potential M&A maneuvers in the absence of transparency from leadership.

Ambarella, Inc. engages in the development of low-power system-on-a-chip (SoC), semiconductors, and software for edge artificial intelligence (AI) applications and intelligent automation. The firm's products include video security, advanced driver assistance (ADAS), electronic mirror, drive recorder, driver or cabin monitoring, autonomous driving, and other robotics applications. It operates through the following geographical segments: Taiwan, Asia Pacific, Europe, North America, and United States. The company was founded by Feng Ming Wang and Leslie D. Kohn on January 15, 2004 and is headquartered in Santa Clara, CA.

Ambarella Inc

Ambarella Inc. is currently trending as investors debate its potential as a pure-play leader in Physical AI and edge computing, with community sentiment oscillating between bullish optimism over its long-term robotics design wins and concerns about high valuations and supply chain pressures. While recent sessions saw significant volatility driven by reports of a potential acquisition, many are now shifting focus toward the company's ability to capitalize on the growing demand for edge AI chips in autonomous systems.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group Inc is currently trending following a positive FDA advisory committee vote for its melanoma therapy, sparking intense community debate over whether this outcome signals a path to approval despite previous regulatory rejections. Investors are actively discussing the potential for a short squeeze alongside concerns about the company's financial health, the risk of significant dilution, and the possibility of a final FDA decision coming as early as this weekend.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is currently trending as investors grapple with escalating bond market volatility and rising long-term yields, which many community members believe signal significant risks to the broader equity market. Conversations are dominated by intense debate over whether the current interest rate environment is a signal of a looming recession or a tactical opportunity for fixed-income exposure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SLS Big Pharma won&#39;t just pay they will fight each other to overpay. The patent cliff turns SELLAS from a luxury into a necessity.

By 2028, Merck alone loses $25B in annual Keytruda revenue. They cannot replace that with &quot;maybe&quot; drugs. A Phase 3 asset with an 80% cure fraction is a &quot;Must-Have.&quot; If Merck doesn&#39;t buy it, and BMS or Pfizer does, Merck is effectively out of the AML market for a decade. The fear of a competitor owning the &quot;GPS Monopoly&quot; is what drives the overpayment.

The GIA Penalty for Big PharmaIf SELLAS decides to GIA: SELLAS uses its 20M RSU pool to poach the very executives who currently run Big Pharma’s oncology wings. SELLAS builds its own nimble, elite sales force, proving that BP’s &quot;massive infrastructure&quot; is no longer needed for a targeted, curative vaccine. SELLAS sets the price, taking 100% of the profit. BP gets $0.

Polsky007

Dingus McKringleberry

Hawk1979

Zoran

Glenn Wilson

EasyLode

Tony M

Richard

Szepen

Zschopower

ming yu

Arturas Paulikas

Hunt McKenzie

Chris

Longnstrongdong

StockTwits for iOS

SELLAS Life Sciences Group Inc

 Big Pharma won't just pay they will fight each other to overpay. The patent cliff turns SELLAS from a luxury into a necessity.

By 2028, Merck alone loses $25B in annual Keytruda revenue. They cannot replace that with "maybe" drugs. A Phase 3 asset with an 80% cure fraction is a "Must-Have." If Merck doesn't buy it, and BMS or Pfizer does, Merck is effectively out of the AML market for a decade. The fear of a competitor owning the "GPS Monopoly" is what drives the overpayment.

The GIA Penalty for Big PharmaIf SELLAS decides to GIA: SELLAS uses its 20M RSU pool to poach the very executives who currently run Big Pharma’s oncology wings. SELLAS builds its own nimble, elite sales force, proving that BP’s "massive infrastructure" is no longer needed for a targeted, curative vaccine. SELLAS sets the price, taking 100% of the profit. BP gets $0.

Duncan Teo

@Duncan74 awesome analysis, agree 100% on the GIA scenario. I could live with that too, but would push back my retirement. The 68,000 shares I own is an integral part of my retirement plan.  100+/share by January or sooner would be great.

StockTwits For Android 

 awesome analysis, agree 100% on the GIA scenario. I could live with that too, but would push back my retirement. The 68,000 shares I own is an integral part of my retirement plan.  100+/share by January or sooner would be great.